Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

POM to P switches: what made Maloff Protect and ellaOne a success?

C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of medicines switching company Maxwellia, about what makes a successful POM to P change

Ms Maxwell has analysed over 30 medicine reclassifications, from prescription-only medicine (POM) to one available to purchase in pharmacies (P), she tells C+D. From ellaOne to Maloff Protect, she knows what makes a successful change.

In this podcast, she speculates on what other switches might be coming down the line, “beyond the cough, cold, pain and gastro categories”. She also explains why pharmacy teams should “embrace” medicine switches to encourage more investment in the sector.

You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching 'Chemist+Druggist podcast' on your preferred android podcast app.

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD005106

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel